Masimo - Eve CCHD Newborn  Screening Application

Eve™ CCHD Newborn Screening Application

Eve combines clinically proven Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry with step-by-step guided workflows to standardize Critical Congenital Heart Disease (CCHD) screenings

Eve simplifies the CCHD screening process, per an established protocol1, by providing visual instructions, animations, an automatic synchronisation algorithm, and a detailed, easy-to-interpret display of screening results.

Streamlined Solution for CCHD Screening with Masimo SET® Pulse Oximetry

Streamlined Solution for CCHD Screening with Masimo SET® Pulse Oximetry

 
Masimo - Eve Animations provide visual

On-screen animations provide visual guidance to assist clinicians through the screening process, including sensor placement.

Masimo - Eve automatic synchronisation algorithm

Automated calculation, with an easy-to-interpret results screen, may reduce manual calculation errors.

Masimo - Eve settings allow clinicians to incorporate perfusion index

Customizable settings allow clinicians to incorporate perfusion index (Pi) measurement, which may increase sensitivity to detection of CCHD2,3

Masimo - Eve EMR integration

Electronic medical record (EMR) integration via Masimo Patient SafetyNet™* or Iris® Gateway facilitates workflow and may help reduce reporting errors.

Masimo SET module plugged into Root

Eve, when used on the Root platform along with the Masimo SET® Module and Radical-7®, allows clinicians to obtain simultaneous measurements from two application sites using one convenient display.

Masimo - Eve CCHD Newborn  Screening Application
  • Eve application is also available on the Rad-97® and Radical-7® Pulse CO-Oximeters®

Step-By-Step Instruction Improves Consistency and Workflow Efficiency

Step-By-Step Instruction Improves Consistency and Workflow Efficiency

 

Step 1

Sensor Placement on Right Hand

Step 2

Sensor Placement on Either Foot

Step 3

Screening Results

Learn More About CCHD Screening with Masimo SET®

Learn More About CCHD Screening with Masimo SET®

 

References:

  1. 1.

     Martin et al. Pediatr. 2020;146(1):e20191650.

  2. 2.

     Siefkes H, et al. Am J Perinatol. 2020; 37(2):158-165.

  3. 3.

     Uygur O et al. Pediatr Neonatol. 2019;60(1):68-73.

  4. * The use of the trademark Patient SafetyNet is under license from University HealthSystem Consortium.

RESOURCES

 
Masimo - Rad-97 with Eve Product Information

Product Information

SET® Module and Eve have obtained CE Marking. Not available in the U.S. or Canada.

For professional use. See instructions for use for full prescribing information, including indications, contraindications, warnings, and precautions.

PLCO-005777/PLM-10862E-0322